Assessing Tissue Viability with StO2
Enables Early Intervention to Improve Patient Outcomes.
Company Overview
ViOptix, Inc. gives clinicians a revolutionary new capability — to obtain non-invasive, objective, real-time measurement of oxygen saturation (StO2) in the soft tissues affected by breast reconstruction and other surgical procedures – to help improve patient surgical outcomes by detecting problems before symptoms are visible.
